| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 2 | 3 | 3 | 6 | 6 | 12 | 12 | 11 | 15 | 15 | 18 | 32 |
| Expenses | 2 | 2 | 2 | 5 | 6 | 11 | 11 | 10 | 13 | 13 | 16 | 30 |
| EBITDA | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Operating Profit % | -12 % | -1 % | -19 % | -2 % | 7 % | 6 % | 1 % | -9 % | 4 % | 5 % | 3 % | 7 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 2 | 0 | 0 | 1 |
| EPS in ₹ | 0.01 | 0.00 | 0.03 | 0.20 | 0.23 | 0.46 | 0.55 | -0.11 | 1.52 | 0.21 | 0.20 | 0.27 |
Veerhealth Care
Veerhealth Care
46.30
+2.20
(4.99%)
Market Cap
92.60 Cr
PE Ratio
163.33
Volume
1,82,256.00
Day High - Low
46.30 - 44.10
52W High-Low
44.15 - 16.70
Key Fundamentals
Market Cap
92.60 Cr
EPS
0.27
PE Ratio
163.33
PB Ratio
3.85
Book Value
11.46
EBITDA
2.15
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
1.76
Debt to Equity
0.11
Actual
Company News
View All News
Veerhealth Care secures a Rs 5.27 crore monthly repeat order for face care products from a leading FMCG firm. The deal adds to Q2FY27 inflow of Rs 696.48 crore, though TTM revenue remains at zero, signaling early-stage execution or reporting lag.
Veerhealth Care secures a Rs 526.84 lakh confirmed order for face care products with a 45-day timeline. This adds to a strong Q2FY27 inflow of Rs 169.64 crore. Book-to-bill context is limited as TTM revenue is reported at zero.
Veerhealth Care secures first export order for Gripe Water from Sudan, valued at ₹15.73 lakhs. The deal marks entry into African pediatric market with 45-day execution timeline.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,944.40 | #1 4,66,526.69 | 38.59 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 51.77 | |
8,300.00 | 2,20,338.92 | 74.86 | 11,067.00 | 13.95 | 2,568 | 65.50 | 73.18 | |
4,924.00 | 1,87,293.13 | 87.37 | 13,886.20 | 20.34 | 2,138 | 3.28 | 51.57 | |
1,467.70 | 1,18,567.46 | 35.44 | 29,044.60 | 2.24 | 3,870 | -39.18 | 57.39 | |
1,119.00 | 1,12,597.58 | 21.71 | 27,657.90 | 17.64 | 5,026 | 7.82 | 50.30 | |
2,300.00 | 1,05,163.48 | #1 19.44 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 35.94 | |
2,438.00 | 1,00,688.42 | 48.72 | 14,636.40 | 14.85 | 1,938 | 29.13 | 43.44 | |
1,854.00 | 1,00,089.41 | 91.92 | 6,867.80 | 22.01 | 890 | #1 123.93 | 79.60 | |
1,158.80 | 96,721.45 | 30.73 | 35,058.60 | 3.90 | 4,158 | -69.10 | 35.65 | |
1,648.00 | 94,822.28 | 26.00 | 34,145.20 | 5.56 | 3,503 | 25.21 | 63.22 |
Growth Rate
Revenue Growth
81.45 %
Net Income Growth
160.00 %
Cash Flow Change
-113.45 %
ROE
-5.38 %
ROCE
-49.90 %
EBITDA Margin (Avg.)
-31.20 %
Yearly Financial Results
Order Value Trend
FY 2026-27 order value₹34.13 Cr
FY 2026-2713 Orders
one of India's Leading FMCG co...
25.99%Not disclosed as per confident...
20.69%one of India's leading FMCG co...
20.28%Unknown
15.43%One of India's Leading FMCG co...
7.18%Others
10.43%Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 14 | 14 | 13 | 15 | 16 | 18 | 19 | 20 | 25 | 28 | 34 | 44 |
| Fixed Assets | 2 | 3 | 3 | 6 | 6 | 10 | 10 | 11 | 12 | 12 | 20 | 23 |
| Current Assets | 8 | 7 | 8 | 7 | 3 | 6 | 7 | 6 | 10 | 14 | 11 | 19 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Other Assets | 12 | 11 | 11 | 9 | 9 | 9 | 9 | 10 | 13 | 16 | 14 | 0 |
| Total Equity & Liabilities | 14 | 14 | 13 | 15 | 16 | 18 | 19 | 20 | 25 | 28 | 34 | 44 |
| Current Liabilities | 1 | 1 | -0 | 1 | 3 | 2 | 2 | 3 | 1 | 3 | 4 | 13 |
| Non Current Liabilities | 1 | 1 | 1 | 0 | 0 | 3 | 3 | 4 | 3 | 4 | 8 | 8 |
| Total Equity | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 21 | 22 | 22 | 23 |
| Reserve & Surplus | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 11 | 2 | 2 | 3 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 10 | 20 | 20 | 20 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 3 | -3 | 1 |
| Investing Activities | 4 | 0 | -0 | -3 | -2 | -2 | -0 | -1 | -2 | -0 | -8 |
| Operating Activities | -4 | 0 | 2 | 2 | 2 | -0 | 1 | 2 | -1 | 3 | -0 |
| Financing Activities | 0 | 0 | -1 | 1 | 0 | 2 | -1 | -0 | 6 | -6 | 10 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 41.92 % | 41.92 % | 41.93 % | 41.93 % | 42.34 % | 44.31 % | 44.36 % | 44.36 % | 30.76 % | 30.76 % | 30.76 % | 30.76 % | 30.41 % | 30.41 % | 30.41 % | 30.41 % | 31.50 % | 31.50 % | 31.50 % | 31.50 % | 31.50 % | 31.91 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 48.78 % | 48.53 % | 48.11 % | 47.50 % | 47.42 % | 44.95 % | 37.12 % | 47.81 % | 55.14 % | 58.28 % | 56.23 % | 56.80 % | 60.05 % | 59.25 % | 58.57 % | 58.53 % | 58.35 % | 57.92 % | 56.97 % | 55.12 % | 54.27 % | 53.97 % |
| Others | 9.29 % | 9.55 % | 9.96 % | 10.57 % | 10.24 % | 10.73 % | 18.52 % | 7.83 % | 14.10 % | 10.96 % | 13.01 % | 12.44 % | 9.54 % | 10.33 % | 11.02 % | 11.06 % | 10.15 % | 10.58 % | 11.53 % | 13.38 % | 14.23 % | 14.12 % |
| No of Share Holders | 3,528 | 3,517 | 3,483 | 3,462 | 3,642 | 3,566 | 3,589 | 3,655 | 3,605 | 3,616 | 6,195 | 6,874 | 10,991 | 10,255 | 11,489 | 11,469 | 11,390 | 11,011 | 10,846 | 10,455 | 10,027 | 9,315 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Aug 2026 |  Quarterly Result Announcement | NA | 13 Aug 2026 | 43.64 | 44.10 |
| 22 Sept 2023 |  Bonus | 1:1 | 22 Sept 2023 | 40.72 | 41.24 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 22.37 | 22.09 |
| 14 Nov 2024 | Quarterly Result Announcement | NA | 14 Nov 2024 | 19.97 | 18.24 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 18.51 | 17.21 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 13.19 | 15.21 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 22.13 | 21.94 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 21.94 | 18.02 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 18.15 | 17.73 |
| 14 Feb 2026 | Quarterly Result Announcement | NA | 14 Feb 2026 | 17.55 | 18.82 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 23.50 | 24.00 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release
5 days ago
5 days agoBoard Meeting Intimation for Consideration And Approval Of Financials For Quarter Ended June 20265 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 24, 2026
Jul 24, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2026
Jul 23, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 22, 2026
Jul 22, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2026
Jul 14, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 13, 2026
Jul 13, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 11, 2026
Jul 11, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 08, 2026
Jul 08, 2026Board Meeting Outcome for Outcome Of The Meeting Of The Preferential Issue Committee Of Board Of
Directors Of Veerhealth Care LimitedJul 02, 2026
Jul 02, 2026Regulation 30 Of The SEBI (Listed Obligations And Disclosure Requirements) Regulations 2015Jun 27, 2026
Jun 27, 2026Closure of Trading WindowJun 24, 2026
Jun 24, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 10, 2026
Jun 10, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 02, 2026
Jun 02, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2026
May 30, 2026Results For The 31St March 2026May 30, 2026
May 30, 2026Board Meeting Outcome for Financial Results For March 2026May 30, 2026
May 30, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Board Meeting Intimation for Consideration And Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31St March 2026 And Recommendation Of Dividend If Any.May 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 15, 2026
May 15, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 01, 2026
May 01, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMay 01, 2026
May 01, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 20, 2026
Apr 20, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 17, 2026
Apr 17, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 16, 2026
Apr 16, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 15, 2026
Apr 15, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 11, 2026
Apr 11, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Apr 08, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 01, 2026
Apr 01, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 31, 2026
Mar 31, 2026Announcement under Regulation 30 (LODR)-Raising of FundsMar 28, 2026
Mar 28, 2026Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Veerhealth Care Limited (Company) In Accordance With Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Mar 28, 2026
Mar 28, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Closure of Trading WindowMar 20, 2026
Mar 20, 2026Board Meeting Intimation for Prior Intimation Under Regulation 29(1)(D) Of The Securities And Exchange Board Of India (LODR) Regulations 2015Mar 20, 2026
Mar 20, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 20, 2026
Mar 20, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 18, 2026
Mar 18, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 25, 2026
Feb 25, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 25, 2026
Feb 25, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2026
Feb 16, 2026Unaudited Financial Results Of The Quarter Ended 31.12.2025.Feb 14, 2026
Feb 14, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.02.2026 For Approving The Unaudited Financial Results For The Quarter Ended 31.12.2025.Feb 14, 2026
Feb 14, 2026Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter Ended 31St December 2025.Feb 06, 2026
Feb 06, 2026Technical Indicators
RSI(14)
Overbought 94.47
ATR(14)
Less Volatile 1.05
STOCH(9,6)
Overbought 95.51
STOCH RSI(14)
Oversold 4.86
MACD(12,26)
Bearish -0.23
ADX(14)
Very Strong Trend 66.20
UO(9)
Bearish 85.28
ROC(12)
Uptrend And Accelerating 7.30
WillR(14)
Overbought -1.23
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
